Literature DB >> 18810668

Palliative surgical bypass for pancreatic and peri-ampullary cancers.

Samrat Mukherjee1, Hemant M Kocher, Robert R Hutchins, Satyajit Bhattacharya, Ajit T Abraham.   

Abstract

BACKGROUND: The optimal method of palliation for patients with unresectable pancreatic and peri-ampullary cancer (PAC) is controversial with surgical bypass or endoscopic stenting, each having advantages and disadvantages. AIMS: We analysed short term outcomes and survival for all patients undergoing surgical palliative bypass procedures.
MATERIALS AND METHODS: All patients undergoing palliative surgical bypass for unresectable PAC from Aug 1999 to July 2007 were identified from our database. Outcomes analysed were peri-operative morbidity, mortality, and overall survival with comparisons from contemporaneous literature.
RESULTS: One hundred eight patients (median age 65 (range 36-86) years; male = 61) had palliative surgical bypass procedures for unresectable PAC. Patients underwent combined biliary and gastric bypass (n = 81, 75%), gastric bypass alone (n = 24, 22.2%) or biliary bypass alone (n = 3, 2.8%). Overall mortality was 6.5% and the morbidity was 15.7%. Median hospital stay was 11 (range 4-54) days. Median survival was 6 (95% confidence interval (CI) = 4.3-7.6) months. No re-explorations for recurrent biliary or gastric obstruction were required. Contemporaneous literature review showed similar results.
CONCLUSION: Surgical bypass performed in a specialist pancreatic center can offer effective palliation for unresectable PAC, with satisfactory outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 18810668     DOI: 10.1007/s12029-008-9020-4

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  54 in total

1.  Operative bypass for incurable cancer of the head of the pancreas.

Authors:  K Welvaart
Journal:  Eur J Surg Oncol       Date:  1992-08       Impact factor: 4.424

2.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.

Authors: 
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

3.  Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice.

Authors:  J R Andersen; S M Sørensen; A Kruse; M Rokkjaer; P Matzen
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

4.  A continuing role for surgical bypass in the palliative treatment of pancreatic carcinoma.

Authors:  A M Isla; T Worthington; A K Kakkar; R C Williamson
Journal:  Dig Surg       Date:  2000       Impact factor: 2.588

5.  Effective palliation of malignant biliary duct obstruction.

Authors:  M A Malangoni; D M McCoy; J D Richardson; L M Flint
Journal:  Ann Surg       Date:  1985-05       Impact factor: 12.969

6.  Biliary stent or surgical bypass in unresectable pancreatic cancer with obstructive jaundice.

Authors:  M K Hyöty; I H Nordback
Journal:  Acta Chir Scand       Date:  1990-05

7.  Surgical palliation for pancreatic cancer. The UCLA experience.

Authors:  S M Singh; W P Longmire; H A Reber
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

8.  Choledochoduodenostomy for palliation in unresectable pancreatic cancer.

Authors:  L A DiFronzo; S Egrari; T X O'Connell
Journal:  Arch Surg       Date:  1998-08

9.  The significance of endoscopically placed prostheses in the management of biliary obstruction due to carcinoma of the pancreas: results of nonoperative decompression in 277 patients.

Authors:  J H Siegel; H Snady
Journal:  Am J Gastroenterol       Date:  1986-08       Impact factor: 10.864

10.  Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction.

Authors:  P H Davids; A K Groen; E A Rauws; G N Tytgat; K Huibregtse
Journal:  Lancet       Date:  1992 Dec 19-26       Impact factor: 79.321

View more
  4 in total

1.  Is intraoperative confirmation of malignancy during pancreaticoduodenectomy mandatory?

Authors:  Giuseppe Garcea; Matthew S Metcalfe; David P Berry; Gavin S Robertson; David M Lloyd; Ashley R Dennison
Journal:  J Gastrointest Surg       Date:  2011-10-28       Impact factor: 3.452

2.  Endoscopic stenting versus operative gastrojejunostomy for malignant gastric outlet obstruction-a systematic review and meta-analysis of randomized and non-randomized trials.

Authors:  Vinayak Nagaraja; Guy D Eslick; Michael R Cox
Journal:  J Gastrointest Oncol       Date:  2014-04

3.  Biliary stenting versus surgical bypass for palliation of periampullary malignancy.

Authors:  Mehrdad Nikfarjam; Andrew K Hadj; Vijayaragavan Muralidharan; Niall Tebbutt; Michael A Fink; Robert M Jones; Graham Starkey; Rhys B Vaughan; Alexander W Marshall; Christopher Christophi
Journal:  Indian J Gastroenterol       Date:  2012-11-16

4.  Stenting versus gastrojejunostomy for management of malignant gastric outlet obstruction: comparison of clinical outcomes and costs.

Authors:  Ann Roy; Micheline Kim; John Christein; Shyam Varadarajulu
Journal:  Surg Endosc       Date:  2012-05-02       Impact factor: 4.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.